Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?

Tietueen suppeat tiedot
dc.contributor.authorLaurila Sanna
dc.contributor.authorRebelos Eleni
dc.contributor.authorHonka Miikka-Juhani
dc.contributor.authorNuutila Pirjo
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.contributor.organization-code1.2.246.10.2458963.20.40502528769
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code2609810
dc.contributor.organization-code2609820
dc.converis.publication-id67265386
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/67265386
dc.date.accessioned2025-08-27T23:38:19Z
dc.date.available2025-08-27T23:38:19Z
dc.description.abstract<p>Secretin is the first hormone that has been discovered, inaugurating the era and the field of endocrinology. Despite the initial focus, the interest in its actions faded away over the decades. However, there is mounting evidence regarding the pleiotropic beneficial effects of secretin on whole-body homeostasis. In this review, we discuss the evidence from preclinical and clinical studies based on which secretin may have a role in the treatment of obesity.<br></p>
dc.identifier.jour-issn1664-2392
dc.identifier.olddbid204339
dc.identifier.oldhandle10024/187366
dc.identifier.urihttps://www.utupub.fi/handle/11111/44191
dc.identifier.urlhttps://www.frontiersin.org/article/10.3389/fendo.2021.737686
dc.identifier.urnURN:NBN:fi-fe2021102752680
dc.language.isoen
dc.okm.affiliatedauthorLaurila, Sanna
dc.okm.affiliatedauthorRebelos, Eleni
dc.okm.affiliatedauthorHonka, Miikka
dc.okm.affiliatedauthorNuutila, Pirjo
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherFrontiers in Endocrinology
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.doi10.3389/fendo.2021.737686
dc.relation.ispartofjournalFrontiers in Endocrinology
dc.relation.volume12
dc.source.identifierhttps://www.utupub.fi/handle/10024/187366
dc.titlePleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Name:
fendo-12-737686.pdf
Size:
647.78 KB
Format:
Adobe Portable Document Format
Description:
Publisher's version
Lataa

Kokoelmat

Rinnakkaistallenteet